Russia makes more than USD 300 million in vaccine sales

RUSSIA / FSU POLITICS - In Brief 09 Aug 2021 by Alex Teddy
On August 4 a news website (RBC) published data from the Ministry of Trade. In the first five months of 2021 Russia sold over USD 300 million. This figure includes non-coronavirus vaccines. In the first months of 2020 it was USD 10 million worth of vaccines sold abroad. Millions of doses of Sputnik V have been sold to Argentina, Kazakhstan, Belarus, Hungary, Serbia and various Central American countries. Sputnik V has been plagued by late production and delivery. Customers have been exasperated by this. Russian vaccine exports are not keeping pace with its competitors. Chinese vaccine exports increased 100 times over during the first five months of 2021. China made USD 1.8 billion in that time period. The EU made USD 6.4 billion and the US made more than USD 1.5 billion. Although Sputnik V was the first in the world, a golden opportunity has been missed. Russia has not been profited anything like as much as it should have from the vaccine. Moscow also hoped that Sputnik would lead to countries buying other Russian medicines.

Now read on...

Register to sample a report

Register
Sign-in
Forgot your password?
Copyright 2025 GlobalSource Partners. All rights reserved. This is prepared for GlobalSource Partners’ clients and may not be redistributed, reproduced, stored in a retrieval system, retransmitted or disclosed, in whole or in part, or in any form or manner, without the express written consent of GlobalSource Partners. This is distributed simultaneously to our website and other portals used by GlobalSource Partners. The information herein was obtained from various sources and is believed to be reliable but GlobalSource Partners does not warrant its completeness or accuracy. Neither GlobalSource Partners nor any Country Analyst, officer or employee accepts any liability whatsoever for any direct, indirect or consequential damages or losses rising from any use of this or its contents.